278 related articles for article (PubMed ID: 15777604)
1. Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects.
Kempsford R; Handel M; Mehta R; De Silva M; Daley-Yates P
Respir Med; 2005 Apr; 99 Suppl A():S11-9. PubMed ID: 15777604
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
4. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
5. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
[TBL] [Abstract][Full Text] [Related]
7. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
[TBL] [Abstract][Full Text] [Related]
8. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
[TBL] [Abstract][Full Text] [Related]
9. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
Mackie AE; McDowall JE; Ventresca P; Bye A; Falcoz C; Daley-Yates PT
Clin Pharmacokinet; 2000; 39 Suppl 1():17-22. PubMed ID: 11140429
[TBL] [Abstract][Full Text] [Related]
10. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
Tripp K; McVicar WK; Nair P; Corren J; Pleskow WW; Goodwin E; Baumgartner RA; Hanrahan JP
J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
[TBL] [Abstract][Full Text] [Related]
11. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
Boccuzzi SJ; Wogen J; Roehm JB
Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
Hermann R; Ruus P; Schneider E; de Mey C
Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
[TBL] [Abstract][Full Text] [Related]
13. Equivalent asthma control and systemic safety of inhaled budesonide delivered via HFA-134a or CFC propellant in a broad range of doses.
Grzelewska-Rzymowska I; Malolepszy J; de Molina M; Sladek K; Zarkovice J; Siergiejko Z;
Respir Med; 2003 Nov; 97 Suppl D():S10-9. PubMed ID: 14753247
[TBL] [Abstract][Full Text] [Related]
14. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Bronsky E; Ekholm BP; Klinger NM; Colice GL
J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
[TBL] [Abstract][Full Text] [Related]
16. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
[TBL] [Abstract][Full Text] [Related]
17. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG; Millar AB; Sykes AP
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[TBL] [Abstract][Full Text] [Related]
19. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH
Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
[TBL] [Abstract][Full Text] [Related]
20. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
Milanowski J; Qualtrough J; Perrin VL
Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]